The dopamine D2 partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 222-226

  Zhang, Dengke ^a,b   Wang, Xuyi ^b   Xiang, Xiaojun ^b   Chen, Hongxian ^b   Zhang, Jian ^a   Su, Qiaorong ^a   Hao, Wei ^b  

^a SHAOXING UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dopamine D2 partial agonist; Fixed ratio schedule; Heroin; Progressive ratio schedule; Self administration; Terguride

Indexed keywords

DIAMORPHINE; DOPAMINE 2 RECEPTOR; SUCROSE; TERGURIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SELF ADMINISTRATION; HEROIN DEPENDENCE; MALE; NONHUMAN; OPIATE ADDICTION; PARTIAL AGONISM; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEROIN DEPENDENCE; LISURIDE; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS; SUCROSE;

EID: 77957810558     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.08.002     Document Type: Article

References (41)

1. Bono G., Balducci C., Richelmi P., Koob G.F., Pulvirenti L. Dopamine partial receptor agonists reduce ethanol intake in the rat. Eur J Pharmacol 1996, 296:233-238.
2. Clark D., Furmidge L.J., Petry N., Tong Z.Y., Ericsson M., Johnson D. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy. Psychopharmacology 1991, 105:381-392.
3. Gal K., Gyertyan I. Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats. Brain Res Bull 2003, 61:595-601.
4. Greenwell T.N., Funk C.K., Cottone P., Richardson H.N., Chen S.A., Rice K.C., et al. Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addict Biol 2009, 14:130-143.
5. Haile C.N., Kosten T.A., Kosten T.R. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse 2008, 34:355-381.
6. Hemby S.E., Martin T.J., Co C., Dworkin S.I., Smith J.E. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exp Ther 1995, 273:591-598.
7. Hemby S.E., Smith J.E., Dworkin S.I. The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther 1996, 277:1247-1258.
8. Hoefer M.E., Voskanian S.J., Koob G.F., Pulvirenti L. Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat. Pharmacol Biochem Behav 2006, 83:403-409.
9. Izzo E., Orsini C., Koob G.F., Pulvirenti L. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacol Biochem Behav 2001, 68:701-708.
10. Kleber H.D. Pharmacologic treatments for heroin and cocaine dependence. Am J Addict 2003, 12:S5-S18.
11. Koob G.F., Kenneth Lloyd G., Mason B.J. Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov 2009, 8:500-515.
12. Kreek M.J., Zhou Y., Butelman E.R., Levran O. Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol 2009, 9:74-80.
13. Leone P., Pocock D., Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 1991, 39:469-472.
14. Liu Z.H., Jin W.Q., Zhang H.P., Chen X.J., Jin G.Z. Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand. Pharmacol Biochem Behav 2003, 75:289-294.
15. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388:586-589.
16. McDougall S.A., Hernandez R.M., Reichel C.M., Farley C.M. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats. Psychopharmacology 2005, 178:431-439.
17. McFarland K., Ettenberg A. Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology 1995, 122:346-350.
18. McFarland K., Ettenberg A. Haloperidol does not attenuate conditioned place preferences or locomotor activation produced by food- or heroin-predictive discriminative cues. Pharmacol Biochem Behav 1999, 62:631-641.
19. Mello N.K., Negus S.S. Effects of flupenthixol and quadazocine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. Neuropsychopharmacology 1999, 21:575-588.
20. Mutschler N.H., Bergman J. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology 2002, 160:362-370.
21. Nawata Y., Yamamoto T. Drug self-administration methods to the study of drug craving (drug seeking behavior). Nihon Arukoru Yakubutsu Igakkai Zasshi 2008, 43:158-165.
22. Orsini C., Koob G.F., Pulvirenti L. Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 2001, 25:789-792.
23. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse. Neurosci Biobehav Rev 2006, 30:215-238.
24. Platt D.M., Rowlett J.K., Spealman R.D. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 2000, 293:1017-1026.
25. Platt D.M., Rowlett J.K., Spealman R.D. Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology 2001, 157:208-216.
26. Platt D.M., Rodefer J.S., Rowlett J.K., Spealman R.D. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology 2003, 166:298-305.
27. Pulvirenti L., Koob G.F. Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 1994, 15:374-379.
28. Pulvirenti L., Balducci C., Piercy M., Koob G.F. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 1998, 286:1231-1238.
29. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 2006, 11:2-38.
30. Self D.W., Stein L. The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 1992, 582:349-352.
31. Shabat-Simon M., Levy D., Amir A., Rehavi M., Zangen A. Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area. J Neurosci 2008, 28:8406-8416.
32. Sibole J.M., Matea P.J., Krall C.M., McDougall S.A. Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats. Pharmacol Biochem Behav 2003, 76:27-34.
33. Sorensen G., Sager T.N., Petersen J.H., Brennum L.T., Thogersen P., Hee Bengtsen C., et al. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology 2008, 199:37-46.
34. Stafford D., LeSage M.G., Glowa J.R. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology (Berl) 1998, 139:169-184.
35. Tadori Y., Kitagawa H., Forbes R.A., McQuade R.D., Stark A., Kikuchi T. Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912. Eur J Pharmacol 2007, 574:103-111.
36. Thomsen M., Caine S.B. Chronic intravenous drug self-administration in rats and mice. Curr Protoc Neurosci 2005, 9:20-24.
37. Vaccarino F.J., Amalric M., Swerdlow N.R., Koob G.F. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav 1986, 24:61-65.
38. Wang Y., Zhang F., Tang S., Lai M., Hao W., Zhang Y., et al. Lack of effect of habenula lesion on heroin self-administration in rats. Neurosci Lett 2009, 461:167-171.
39. Woolverton W.L., Ranaldi R. Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement. Pharmacol Biochem Behav 2002, 72:803-809.
40. Xi Z.X., Fuller S.A., Stein E.A. Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J Pharmacol Exp Ther 1998, 284:151-161.
41. Zernig G., Ahmed S.H., Cardinal R.N., Morgan D., Acquas E., Foltin R.W., et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 2007, 80:65-119.